The capital markets regulator, Securities and Exchange Board of India, is likely to begin a

preliminary inquiry into the $4 billion merger deal bet!een pharma giants Sun "harmaceutical and #anbaxy $aboratories to check !hether insider trading norms !ere %iolated& The mo%e follo!s a sharp rise in trading acti%ity in the shares of #anbaxy days before the deal !as announced& 'The trading pattern suggests certain entities could ha%e traded !ith possession of inside information on the deal& If !e are able to establish a link, !e !ill take action,( said a Sebi source&